These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27902343)

  • 1. Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.
    Naciute M; Mieliauskaite D; Rugiene R; Nikitenkiene R; Jancoriene L; Mauricas M; Nora-Krukle Z; Murovska M; Girkontaite I
    J Gen Virol; 2016 Dec; 97(12):3302-3312. PubMed ID: 27902343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients.
    Naciute M; Mieliauskaite D; Rugiene R; Maciunaite G; Mauricas M; Murovska M; Girkontaite I
    Cytokine; 2017 Aug; 96():41-48. PubMed ID: 28288327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
    Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
    J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
    Kozireva SV; Zestkova JV; Mikazane HJ; Kadisa AL; Kakurina NA; Lejnieks AA; Danilane IN; Murovska MF
    J Rheumatol; 2008 Jul; 35(7):1265-70. PubMed ID: 18484700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19.
    Kakurina N; Kadisa A; Lejnieks A; Mikazane H; Kozireva S; Murovska M
    Medicina (Kaunas); 2015; 51(1):18-24. PubMed ID: 25744771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
    Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
    J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
    Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
    J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis.
    Peterlana D; Puccetti A; Beri R; Ricci M; Simeoni S; Borgato L; Scilanga L; Cerù S; Corrocher R; Lunardi C
    J Rheumatol; 2003 Sep; 30(9):1907-10. PubMed ID: 12966589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Numbers of CD4
    Naciute M; Maciunaite G; Mieliauskaite D; Rugiene R; Zinkeviciene A; Mauricas M; Murovska M; Girkontaite I
    In Vivo; 2017; 31(2):181-185. PubMed ID: 28358698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
    Juhl D; Görg S; Hennig H
    Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
    Escher F; Modrow S; Sabi T; Kühl U; Lassner D; Schultheiss HP; Noutsias M
    Med Sci Monit; 2008 Dec; 14(12):CR589-97. PubMed ID: 19043365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of parvovirus B19 infection in patients with chronic kidney disease under hemodialysis: A multicenter study.
    Alves ADR; Langella BB; Barbosa JR; Lima DM; Colares JKB; Garcia RCNC; Pinto MA; Villar LM; Amado LA
    Int J Infect Dis; 2020 Nov; 100():350-356. PubMed ID: 32927082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between arthritis and human parvovirus B19 infection.
    Caliskan R; Masatlioglu S; Aslan M; Altun S; Saribas S; Ergin S; Uckan E; Koksal V; Oz V; Altas K; Fresko I; Kocazeybek B
    Rheumatol Int; 2005 Nov; 26(1):7-11. PubMed ID: 15322815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
    Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
    J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Look-back study on recipients of Parvovirus B19 (B19V) DNA-positive blood components.
    Juhl D; Özdemir M; Dreier J; Görg S; Hennig H
    Vox Sang; 2015 Nov; 109(4):305-11. PubMed ID: 26053938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.
    Ennis O; Corcoran A; Kavanagh K; Mahon BP; Doyle S
    J Clin Virol; 2001 Aug; 22(1):55-60. PubMed ID: 11418353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
    Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
    Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of parvovirus B19 DNA in blood: Viruses or DNA remnants?
    Molenaar-de Backer MW; Russcher A; Kroes AC; Koppelman MH; Lanfermeijer M; Zaaijer HL
    J Clin Virol; 2016 Nov; 84():19-23. PubMed ID: 27664778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis.
    Zakrzewska K; Azzi A; De Biasi E; Radossi P; De Santis R; Davoli PG; Tagariello G
    J Med Virol; 2001 Oct; 65(2):402-7. PubMed ID: 11536251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.
    Tzang BS; Tsai CC; Tsay GJ; Wang M; Sun YS; Hsu TC
    Clin Chim Acta; 2009 Jul; 405(1-2):76-82. PubMed ID: 19362081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.